PPWR & Pharmaceutical Blister Converters: PVC Phase-Out, Mono-PP & Mono-PET, Aclar Barriers
PPWR & Pharmaceutical Blister Packaging Converters: PVC Phase-Out, Mono-PP and Mono-PET Migration, Aclar Barriers and the August 2026 Deadline
Thermoformed pharmaceutical blisters are the format-of-record for European medicines. Roughly 95% of prescription and OTC oral solid doses placed on the EU market today ship in PVC, PVC-PVDC or Alu/Alu blister cards. That long-stable supply chain is now under simultaneous pressure from Regulation (EU) 2025/40, from chemical-recycling capacity decisions made by the polymer majors, and from a new wave of recyclable mono-material structures that will be presented in detail at The Pharma Days 2026 in Geneva on May 27–28. For thermoforming converters, blister-film extruders and lidding-foil converters supplying pharma fillers, that combination defines the next 36 months of capital and product-development decisions.
Primary pharmaceutical packaging benefits from extended PPWR transitional periods — the recyclability grade requirement under Article 6 and the recycled-content quotas under Article 7 do not bite for medicinal blister formats until 2035 and 2040 respectively. But Article 10 minimisation, Article 5 substance restrictions (heavy metals, intentionally-added PFAS), Article 39 Declarations of Conformity, Article 12 Digital Product Passport data and the Annex VIII technical-file obligations all apply on the same August 12, 2026 horizon as every other packaging segment. And OTC, nutraceutical, food-supplement and medical-device blisters do not get the pharma carve-out at all — they are fully in scope. Converters need a playbook that splits cleanly across both sub-segments.
Why the Carve-Out Is Narrower Than It Looks
The transitional regime in Article 6 and Article 7 of Regulation (EU) 2025/40 covers medicinal products and medical devicesas defined in Directives 2001/83/EC, 2001/82/EC and Regulation (EU) 2017/745. It does not cover food supplements, vitamins, nutraceuticals, cosmetic-adjacent wellness products or veterinary OTC formats — even when those products use exactly the same thermoformed blister geometry on exactly the same Uhlmann or IMA line. SÜDPACK Medica's recyclable mono-PP blister concept was originally developed for nutraceuticals precisely because that sub-segment lands inside the August 12, 2026 deadline with no carve-out.
The practical consequence for blister-film converters is that the first wave of recyclable structures will be qualified on nutraceutical and OTC SKUs in 2026–2028, with prescription migration following as Article 7 recycled-content thresholds approach in 2035–2040. Converters sequencing capital around "pharma is exempt" will be wrong on every nutraceutical, food-supplement and medical-device SKU they print today.
The Blister-Converter Obligation Stack
| Obligation | PPWR Article | Deadline | What the Blister Converter Must Do |
|---|---|---|---|
| Heavy-metal limit (Pb + Hg + Cd + Cr(VI) < 100 mg/kg) | Article 5 & Annex V | In force (Jan 1, 2026) | Audit pigment masterbatch in coloured PVC and aluminium-foil printing inks; remove cadmium-yellow and lead-chromate colourants from blister cards and patient cartons |
| Intentionally-added PFAS ban (food-contact applies to nutraceuticals, OTC food supplements) | Article 5 & Annex V | August 12, 2026 | Eliminate fluorinated slip masterbatches in lidding films, fluorinated release coatings on COC top webs, fluorotelomer-treated patient-information leaflets |
| Article 10 minimisation (volume & weight) | Article 10 & Annex IV | August 12, 2026 | Audit cavity geometry, web waste, blister-card empty space, secondary carton sizing; document design rationale per SKU in the Annex IV file |
| Recyclability grade (Annex II Table 3) per construction | Article 6 & Annex II | Aug 12, 2026 (nutra/OTC); 2035 (medicinal) | Validate non-medicinal blisters via RecyClass / EPBP / Cyclos-HTP; below-Grade-C banned from Jan 1, 2030 for in-scope segments |
| Declaration of Conformity per packaging unit | Article 39 & Annex VIII | August 12, 2026 | Issue a DoC per blister SKU with film grades, lidding chemistry, ink/varnish list, adhesive class and barrier evidence |
| Digital Product Passport data block | Article 12 | August 12, 2028 | Provide structured data (polymer identity, barrier layer, coating, ink, recycled-content claim) for QR-readable DPP on blister wallet or carton |
| Recycled-content quotas in plastic packaging | Article 7 | Jan 1, 2030 (out-of-scope segments); 2040 (medicinal) | Lock in EFSA-positive food-grade rPET supply via mass balance for OTC/nutra; sequence ISO 22095 chain-of-custody contracts now |
The Five Grade-Killers in a Pharmaceutical Blister Construction
Even where Article 6 grading does not yet apply to a specific medicinal SKU, the Article 39 DoC and Article 12 DPP both require the converter to declare the recyclability classification of the packaging unit. Brand-owner procurement teams in nutraceuticals and OTC are already running RecyClass REP-PET v6 and REP-PP v6.1 evaluation protocols on candidate blister structures. The same five components keep dragging an otherwise mono-material blister down to grade C or worse:
| Component | Grade Impact | What the Converter Must Do |
|---|---|---|
| PVC bottom web with PVDC barrier coating | Chlorinated polymer disqualifies the blister from the PET #1 and PP #5 streams; sorted to landfill or incineration in most member states | Migrate to mono-PET (Klöckner Pentaplast kpNext R1, Perlen Packaging PerlaPet) or mono-PP (SÜDPACK PharmaGuard, TekniPlex Tekniflex COC + PP lidding) |
| Aluminium push-through lidding foil > 5% of total weight | Foil-laminated polymer is non-recyclable in PE/PP/PET streams; Alu/Alu cold-form blisters fail every polymer protocol | Replace push-through aluminium with peelable mono-polymer lidding (Huhtamaki Push Tab, KP Films kpNext) for moisture-tolerant APIs; reserve Alu/Alu for highest-barrier applications only |
| EVOH or PVDC barrier > 5% layer ratio | RecyClass REP-PET v6 and REP-PP v6.1 cap non-target polymer at 5% by weight; thicker barrier disqualifies | Replace EVOH/PVDC with vapour-deposited SiOx or AlOx oxygen barriers, or use COC (cyclic olefin copolymer) at < 5% load with PP lidding |
| Solvent-based gravure inks with chlorinated or aromatic vehicles on aluminium lidding | Migration risk under EuPIA Suitability List; high VOC and contamination of recycling stream | Migrate to low-migration LED-UV or water-based flexo inks compliant with EuPIA Suitability List 2024 and Swiss Ordinance RS 817.023.21 |
| Heat-seal lacquer with PVdC or fluoropolymer chemistry | Halogenated heat-seal lacquers add chlorine load; PFAS slip aids banned outright Aug 12, 2026 in food-contact lidding | Migrate to EVA, EMA, acrylic dispersion or peelable PP-co-PE seal lacquers; document supplier declarations to molecule level |
Why Aclar and PCTFE Need a Specific Strategy
Polychlorotrifluoroethylene (PCTFE), best known under the Aclar brand, delivers the lowest moisture vapour transmission rate of any commercial blister film and is the workhorse barrier for moisture-sensitive APIs. PCTFE is a fluoropolymer. Article 5 of Regulation (EU) 2025/40 prohibits intentionally-added PFAS in food-contact packaging from August 12, 2026, but the medicinal-product carve-out preserves PCTFE for prescription drugs through the transitional period. Converters running mixed pharma / nutraceutical lines must segregate PCTFE-bearing structures from any food-supplement SKU passing through the same thermoformer, and document the segregation in the Annex VIII technical file. TekniPlex Healthcare's Aclar laminates remain available for medicinal applications; the same tooling cannot be used for an Article 5-bound food-supplement SKU without a written compliance-equivalence assessment.
Mono-PP, Mono-PET and the Capacity Gap
Three converter-led migration paths now have referenceable, RecyClass-validated production lines:
- Mono-PET (PETE #1 stream) — Klöckner Pentaplast kpNext R1, Perlen Packaging PerlaPet, Bayer Aleve OTC blister card. RecyClass A grading achievable for low-to-moderate moisture barrier APIs; Romaco Noack N 760 plate-sealing line runs four-lane mono-PET at up to 150 blisters/min. Article 7 30% PCR target hits this stream first.
- Mono-PP with COC barrier and PP lidding (PP #5 stream)— TekniPlex Tekniflex COC films paired with barrier PP lidding, SÜDPACK PharmaGuard mono-PP system. COC delivers moisture barrier at < 5% layer load so the structure remains RecyClass-compliant. Pharmaworks blister machines tooled specifically for mono-PP since 2025 deliver pre-validated cycle parameters.
- Polymer push-through lidding — Huhtamaki Push Tab achieves a RecyClass A certificate by replacing aluminium push-through with a paper-polymer composite that releases the dose without foil. Removes the largest single grade-killer in the conventional Alu/PVC stack.
The capacity gap is not film extrusion; it is qualified pharma fillers. EU Annex 1 GMP qualification of a new blister film is a 12–18 month exercise per SKU. Converters that have already run ICH Q1A(R2) stability programmes on mono-PET and mono-PP candidates, with leachables/extractables data per USP <1663> / <1664> in hand, will win the OTC and nutraceutical migration wave this summer. Those that wait for a brand-owner RFQ to start qualification will not finish in time for Article 10 / Article 39 enforcement.
The Article 10 Minimisation Trap on Pharma Blisters
Article 10 plus Annex IV require that every packaging unit be minimised in weight, volume and empty space. Pharmaceutical blister cards have historically over-sized cavities for visual product differentiation, included unprinted dose bands as "buffer space" and used double-walled secondary cartons sized to the supply-chain palette rather than the dose. Annex IV forces a per-SKU justification. For converters this means producing the design-for-minimisation rationale the brand owner files as part of the Annex VIII technical file. Three remediation paths recur:
- Right-size cavity to dose envelope (eliminate > 2 mm headspace around tablet/capsule)
- Move from rigid double-wall secondary carton to single-ply folding carton with QR-coded DPP
- Eliminate decorative PIL inserts in favour of QR-linked digital leaflets where Article 11 of Directive 2001/83/EC permits
None of these touches the API-contact face of the blister, so they can be implemented without a new stability programme — but they all require the converter to publish a structured weight / volume / empty-space dataset per SKU.
The Data Handoff: What Pharma and Nutraceutical Brand Owners Will Demand
From August 12, 2026, every brand-owner Annex VIII technical file must be traceable back to the converter's specification sheet. For thermoformed blister and lidding converters supplying pharma, OTC and nutraceutical fillers, that means a structured, machine-readable dataset per SKU containing at least:
- Bottom-web polymer identity, layer count, individual layer thickness (µm), barrier layer chemistry and percentage by weight
- Lidding-foil construction: aluminium gauge or polymer film identity, primer / heat-seal lacquer chemistry, print-side lacquer system
- RecyClass / EPBP / Cyclos-HTP test report with predicted Annex II grade for non-medicinal SKUs
- EuPIA Suitability List declaration for inks, varnishes and overprint coatings; Swiss Ordinance RS 817.023.21 compliance
- USP <1663> extractables and <1664> leachables data set against the API solvent / pH window
- ICH Q1A(R2) stability summary at 25 °C/60% RH and 40 °C/75% RH for ≥ 6 months
- Recycled-content claim with ISCC PLUS / RedCert² mass-balance certificate or product-specific certificate (Article 7)
- Proof of absence of intentionally-added PFAS in food-contact lidding for nutraceutical / supplement SKUs
- Heavy-metal compliance declaration per Annex V (Pb + Hg + Cd + Cr(VI) < 100 mg/kg sum)
- Sorting pictogram, polymer code, DPP-ready data block per Article 12
Converters able to publish this back to brand-owner procurement as a structured data export — not a scanned PDF, not a Word document — will hold their job book through 2030. TekniPlex Healthcare, Klöckner Pentaplast, SÜDPACK Medica, Huhtamaki and Perlen Packaging have all announced PPWR data-portal programmes on the supplier side; the commercial signal is unambiguous.
Action Plan for Pharmaceutical Blister Converters
- Segment your job book by carve-out status — split SKUs into medicinal-product (Directive 2001/83/EC), medical-device (Regulation (EU) 2017/745) and out-of-scope (food supplement, OTC nutraceutical, cosmetic-adjacent). The out-of-scope tranche is where Article 6, 7, 10 and 39 bite first.
- Eliminate intentionally-added PFAS now — audit slip masterbatches, release coatings, fluoropolymer heat-seal layers and printed leaflet stock. Reserve PCTFE / Aclar for medicinal SKUs only and document the segregation.
- Stand up a mono-PET and a mono-PP qualification line — book RecyClass REP-PET v6 and REP-PP v6.1 testing on candidate blister + lidding stacks; archive the report in the Annex VIII file. Pharma fillers now expect a converter to ship a qualified mono-material option.
- Migrate aluminium push-through where moisture allows — qualify polymer or paper-polymer push-through lidding (Huhtamaki Push Tab, KP Films kpNext) on moisture-tolerant OTC formulations.
- Run an Article 10 cavity / carton audit — measure headspace per SKU, document the design-for-minimisation rationale, sequence secondary-carton down-gauging to clear the August 12, 2026 deadline.
- Lock in EFSA-positive food-grade rPET supply — for OTC and nutraceutical blisters targeting 30% PCR by 2030 (Article 7). ISCC PLUS or RedCert² mass-balance contracts now beat spot-buy in 2029.
- Stand up a structured DoC / DPP data pipeline — every SKU needs a machine-readable spec sheet ready for brand-owner RFQs; PDFs and Excel exports will not scale past a few hundred references.
How PPWR Connect Helps Pharmaceutical Blister Converters
Pharmaceutical, OTC and nutraceutical blisters are where PPWR Articles 5, 6, 7, 10, 12 and 39 intersect with Annex 1 GMP, EuPIA migration rules, USP <1663> / <1664> programmes and the medicinal-product transitional regime — and where the converter's choice of bottom web, barrier chemistry, lidding foil, heat-seal lacquer and ink directly determines whether a non-medicinal SKU lands as RecyClass A, B or C. PPWR Connect gives blister-film extruders, thermoforming converters and lidding-foil decorators a single platform to inventory every active blister construction by carve-out status, run automated Annex II grading on the full bottom-web + barrier + lidding + lacquer + ink stack, intake RecyClass / EPBP / Cyclos-HTP test reports, track PFAS elimination on food-contact lidding, document Article 10 cavity / carton minimisation, sequence ISCC PLUS rPET / rPP procurement against the 2030 horizon and produce audit-ready Declarations of Conformity per market. Converters use the same platform to publish machine-readable component specifications back to their pharma and nutraceutical brand-owner customers — turning PPWR compliance from a reporting burden into a tender-winning differentiator. With August 12, 2026 less than three months away, the blister converters that start structured data collection and mono-PP / mono-PET qualification today are the ones that will hold their pharma and nutraceutical job book into 2030.